Outcomes of damage control surgery in perforated sigmoid diverticulitis: a comparison before and after implementing a new treatment algorithm - Top-Institutions - MDSpire

Outcomes of damage control surgery in perforated sigmoid diverticulitis: a comparison before and after implementing a new treatment algorithm

  • By

  • Burgard, Marie

  • Pugin, François

  • Adamina, Michel

  • Cherbanyk, Floryn

  • February 27, 2026

  • 0 min

Share

Top Institutions in Obgyn

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Colorectal Surgery
    • Emergency Surgery
    • Surgical Research

  • #2

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Colorectal Surgery
    • Acute Care Surgery
    • Surgical Outcomes Research

  • #3

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Colorectal Surgery
    • Trauma and Acute Care Surgery
    • Clinical Research

  • #4

    University of Pittsburgh Medical Center (UPMC)
    University of Pittsburgh Medical Center (UPMC)

    Pittsburgh, PA

    Key Differentiators

    • Colorectal Surgery
    • Trauma Surgery
    • Surgical Critical Care

  • #5

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Colorectal Surgery
    • Surgical Research
    • Emergency Surgery

Original Source(s)

Outcomes of damage control surgery in perforated sigmoid diverticulitis: a comparison before and after implementing a new treatment algorithm

  • by Burgard, Marie, Pugin, François, Adamina, Michel, Cherbanyk, Floryn

  • February 27, 2026

Related Content

Comparison of surgical outcomes of robotic complete mesocolic excision for right-sided colon cancer in obese versus non-obese patients

The impact of body mass index on prognosis in patients with colon carcinoma

Deficiency in Epithelium RAD50 Aggravates UC via IL-6-Mediated JAK1/2-STAT3 Signaling and Promotes Development of Colitis-Associated Cancer in Mice